EZM 2302
EZM 2302 (EZM2302, GSK 3359088) is a potent, selective, orally available arginine methyltransferase CARM1 inhibitor with IC50 of 6 nM, with broad selectivity against other HMTases; demonstrates in vitro anti-proliferative activity consistent with specific methyl mark inhibition with IC50 of <100 nM in 9/15 multiple myeloma cell lines, decreases methylation of PABP1 (IC50 =38 nM) and SmB (IC50=18 nM) ; displays dose-dependent inhibition of CARM1 substrate methylation in vivo, and induces growth inhibition of human multiple myeloma tumor xenografts in mice.
Product Specifications
CAS Number
1628830-21-6
Product Name Alternative
GSK 3359088 | GSK3359088 | EZM2302
Purity
>98% (HPLC)
Solubility
100 mM in DMSO
Smiles
O=C (N (CC1) CCC21CN (C3=NC (C4=CC (OC[C@H] (O) CNC) =CC=C4Cl) =NC (C5=C (C) ON=C5C) =C3C) C2) OC
Molecular Formula
C29H37ClN6O5
Molecular Weight
585.102
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
BCAN, CT (BCAN, BEHAB, CSPG7, Brevican core protein, Brain-enriched hyaluronan-binding protein, Chondroitin sulfate proteoglycan 7) (MaxLight 550) discontinued
STAP1, NT (F56) (BRDG1, Signal-transducing Adaptor Protein 1, Stem Cell Adaptor Protein 1, BCR Downstream-signaling Protein 1, Docking Protein BRDG1) (PE)